On 2025-05-13, Repare Therapeutics Inc. (RPTX) announced earnings per share of $-0.71 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.65.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.56 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.65 | $-0.71 |
| 2025-03-03 | 2024-12-31 | $-0.77 | $-0.67 |
| 2024-11-07 | 2024-09-30 | $-0.83 | $-0.81 |
| 2024-08-06 | 2024-06-30 | $-0.85 | $-0.82 |
| 2024-05-07 | 2024-03-31 | $-0.10 | $0.30 |
| 2024-02-28 | 2023-12-31 | $-0.56 | $-0.67 |
| 2023-11-09 | 2023-09-30 | $-0.86 | $-0.45 |
| 2023-08-09 | 2023-06-30 | $-0.83 | $-0.28 |
| 2023-05-09 | 2023-03-31 | $-0.84 | $-0.83 |
| 2023-02-28 | 2022-12-31 | $-0.73 | $-0.75 |
| 2022-11-09 | 2022-09-30 | $-0.20 | $1.71 |
| 2022-08-04 | 2022-06-30 | $-0.86 | $-0.91 |
| 2022-05-05 | 2022-03-31 | $-0.89 | $-0.83 |
| 2022-03-01 | 2021-12-31 | $-0.75 | $-0.70 |
| 2021-11-10 | 2021-09-30 | $-0.70 | $-0.83 |
| 2021-08-12 | 2021-06-30 | $-0.58 | $-0.71 |
| 2021-05-13 | 2021-03-31 | $-0.49 | $-0.58 |
| 2021-03-04 | 2020-12-31 | $-0.41 | $-0.41 |
| 2020-11-11 | 2020-09-30 | $-0.41 | $-0.37 |
| 2020-08-13 | 2020-06-30 | $-0.43 | $-2.45 |